Stock Information
Apogee Therapeutics Inc (APGE)
Ticker Symbol: APGE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,762.13 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -4.2185
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -36.77%
Latest News
-
Mizuho Maintains Outperform on Apogee Therapeutics, Raises Price Target to $110
Mon, Mar 30, 2026 9:57 AM
Key Financials
Financial data not available